1-8 of 8
Romain Boidot
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CD40 Agonist on Patient-Derived Xenograft Mice for the Treatment of B-Cell Acute Lymphoblastic Leukemia

Pierre-Simon Bellaye, Aleksandra Georgievski, Paola Ballerini, Boutheina Bouslama, Corentin Richard, Romain Boidot, Guillaume Chevreux, Véronique Legros, Julien Guy, Jessica Racine, Bertrand Collin, Carmen Garrido, Ronan Quéré
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (1): 181–196.
https://doi.org/10.1158/1078-0432.CCR-24-1391
Published: 06 January 2025
View article titled, CD40 Agonist on Patient-Derived Xenograft Mice for the Treatment of B-Cell Acute Lymphoblastic Leukemia
Open the PDF for CD40 Agonist on Patient-Derived Xenograft Mice for the Treatment of B-Cell Acute Lymphoblastic Leukemia in another window
Includes: Supplementary data
Journal Articles

Correction: Activity and Safety of Palbociclib in Patients with Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib: A Biomarker-driven Phase II Study

Maud Toulmonde, Jean-Yves Blay, Olivier Bouche, Olivier Mir, Nicolas Penel, Nicolas Isambert, Florence Duffaud, Emmanuelle Bompas, Thomas Esnaud, Romain Boidot, Damien Geneste, François Ghiringhelli, Carlo Lucchesi, Carine A. Bellera, François Le Loarer, Antoine Italiano
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (15): 4859.
https://doi.org/10.1158/1078-0432.CCR-19-1599
Published: 01 August 2019
View article titled, Correction: Activity and Safety of Palbociclib in Patients with Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib: A Biomarker-driven Phase II Study
Open the PDF for Correction: Activity and Safety of Palbociclib in Patients with Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib: A Biomarker-driven Phase II Study in another window
Journal Articles

Activity and Safety of Palbociclib in Patients with Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib: A Biomarker-driven Phase II Study

Maud Toulmonde, Jean-Yves Blay, Olivier Bouche, Olivier Mir, Nicolas Penel, Nicolas Isambert, Florence Duffaud, Emmanuelle Bompas, Thomas Esnaud, Romain Boidot, Damien Geneste, François Ghiringhelli, Carlo Lucchesi, Carine A. Bellera, François Le Loarer, Antoine Italiano
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (15): 4611–4615.
https://doi.org/10.1158/1078-0432.CCR-18-3127
Published: 01 August 2019
View article titled, Activity and Safety of Palbociclib in Patients with Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib: A Biomarker-driven Phase II Study
Open the PDF for Activity and Safety of Palbociclib in Patients with Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib: A Biomarker-driven Phase II Study in another window
Includes: Supplementary data
Journal Articles

Exome Analysis Reveals Genomic Markers Associated with Better Efficacy of Nivolumab in Lung Cancer Patients

Corentin Richard, Jean-David Fumet, Sandy Chevrier, Valentin Derangère, Fanny Ledys, Aurélie Lagrange, Laure Favier, Bruno Coudert, Laurent Arnould, Caroline Truntzer, Romain Boidot, François Ghiringhelli
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (3): 957–966.
https://doi.org/10.1158/1078-0432.CCR-18-1940
Published: 01 February 2019
View article titled, Exome Analysis Reveals Genomic Markers Associated with Better Efficacy of Nivolumab in Lung Cancer Patients
Open the PDF for Exome Analysis Reveals Genomic Markers Associated with Better Efficacy of Nivolumab in Lung Cancer Patients in another window
Includes: Supplementary data
Journal Articles

>Expression profile of apoptosis genes in breast tumors over expressing survivin.

Frédérique Végran, Romain Boidot, Pierre Fumoleau, Lyse Hahnel, Muriel Cadouot, Sarab Lizard-Nacol, Jr.
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (19_Supplement): A82.
Published: 15 August 2014
View article titled, >Expression profile of apoptosis genes in breast tumors over expressing survivin.
Journal Articles

>Gene expression changes after one course of chemotherapy in breast cancer

Romain Boidot, Frédérique Végran, Muriel Cadouot, Lyse Hahnel, Pierre Fumoleau, Sarab Lizard-Nacol, Jr.
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (19_Supplement): A83.
Published: 15 August 2014
View article titled, >Gene expression changes after one course of chemotherapy in breast cancer
Journal Articles

Identification of Cyclooxygenase-2 as a Major Actor of the Transcriptomic Adaptation of Endothelial and Tumor Cells to Cyclic Hypoxia: Effect on Angiogenesis and Metastases

Géraldine Daneau, Romain Boidot, Philippe Martinive, Olivier Feron
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (2): 410–419.
https://doi.org/10.1158/1078-0432.CCR-09-0583
Published: 14 January 2010
View article titled, Identification of Cyclooxygenase-2 as a Major Actor of the Transcriptomic Adaptation of Endothelial and Tumor Cells to Cyclic Hypoxia: Effect on Angiogenesis and Metastases
Open the PDF for Identification of Cyclooxygenase-2 as a Major Actor of the Transcriptomic Adaptation of Endothelial and Tumor Cells to Cyclic Hypoxia: Effect on Angiogenesis and Metastases in another window
Includes: Supplementary data
Journal Articles

Overexpression of Caspase-3s Splice Variant in Locally Advanced Breast Carcinoma Is Associated with Poor Response to Neoadjuvant Chemotherapy

Frédérique Végran, Romain Boidot, Claire Oudin, Jean-Marc Riedinger, Franck Bonnetain, Sarab Lizard-Nacol
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (19): 5794–5800.
https://doi.org/10.1158/1078-0432.CCR-06-0725
Published: 04 October 2006
View article titled, Overexpression of Caspase-3s Splice Variant in Locally Advanced Breast Carcinoma Is Associated with Poor Response to Neoadjuvant Chemotherapy
Open the PDF for Overexpression of Caspase-3s Splice Variant in Locally Advanced Breast Carcinoma Is Associated with Poor Response to Neoadjuvant Chemotherapy in another window